Lauren Ashley Henderson, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphohistiocytosis, Hemophagocytic | 11 | 2024 | 269 | 3.280 |
Why?
|
Systemic Inflammatory Response Syndrome | 12 | 2024 | 619 | 3.180 |
Why?
|
Macrophage Activation Syndrome | 10 | 2024 | 124 | 3.160 |
Why?
|
Immunologic Deficiency Syndromes | 5 | 2019 | 548 | 1.180 |
Why?
|
Rheumatology | 4 | 2023 | 616 | 1.100 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 6 | 2023 | 536 | 1.010 |
Why?
|
Lung Diseases | 4 | 2023 | 1910 | 0.920 |
Why?
|
Pleurisy | 2 | 2013 | 54 | 0.860 |
Why?
|
Synovial Fluid | 4 | 2022 | 393 | 0.840 |
Why?
|
Autoimmunity | 4 | 2019 | 1356 | 0.680 |
Why?
|
Connective Tissue Diseases | 1 | 2022 | 285 | 0.650 |
Why?
|
T-Lymphocytes, Regulatory | 5 | 2023 | 3092 | 0.620 |
Why?
|
Eosinophilia | 1 | 2023 | 557 | 0.620 |
Why?
|
Cell Polarity | 1 | 2021 | 638 | 0.600 |
Why?
|
Child | 40 | 2024 | 80152 | 0.550 |
Why?
|
Severe Combined Immunodeficiency | 3 | 2015 | 229 | 0.540 |
Why?
|
Dyspnea | 2 | 2013 | 1347 | 0.490 |
Why?
|
Biological Products | 1 | 2023 | 915 | 0.450 |
Why?
|
Homeodomain Proteins | 4 | 2019 | 2414 | 0.440 |
Why?
|
Antirheumatic Agents | 3 | 2021 | 1369 | 0.430 |
Why?
|
Th17 Cells | 1 | 2020 | 794 | 0.430 |
Why?
|
Uveitis | 1 | 2016 | 396 | 0.400 |
Why?
|
Arthritis, Rheumatoid | 3 | 2023 | 3753 | 0.400 |
Why?
|
Leukopenia | 1 | 2012 | 213 | 0.390 |
Why?
|
T-Lymphocytes | 6 | 2022 | 10203 | 0.370 |
Why?
|
Inflammation | 8 | 2024 | 10759 | 0.360 |
Why?
|
Child, Preschool | 20 | 2024 | 42224 | 0.360 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1812 | 0.350 |
Why?
|
T-Lymphocytes, Helper-Inducer | 3 | 2023 | 976 | 0.350 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 2 | 2021 | 299 | 0.320 |
Why?
|
Adenosine Deaminase | 2 | 2021 | 250 | 0.300 |
Why?
|
Lung | 4 | 2022 | 9979 | 0.290 |
Why?
|
Heart Defects, Congenital | 1 | 2024 | 4673 | 0.290 |
Why?
|
Humans | 60 | 2024 | 761208 | 0.270 |
Why?
|
Immunoglobulins, Intravenous | 2 | 2021 | 668 | 0.260 |
Why?
|
Immunomodulation | 2 | 2020 | 548 | 0.250 |
Why?
|
Intercellular Signaling Peptides and Proteins | 3 | 2024 | 1651 | 0.250 |
Why?
|
Interleukin-18 | 2 | 2024 | 250 | 0.250 |
Why?
|
Adolescent | 17 | 2024 | 88298 | 0.230 |
Why?
|
Ferritins | 2 | 2024 | 596 | 0.230 |
Why?
|
Consensus | 4 | 2023 | 3134 | 0.220 |
Why?
|
Glucocorticoids | 2 | 2024 | 2159 | 0.210 |
Why?
|
Wiskott-Aldrich Syndrome | 1 | 2023 | 131 | 0.210 |
Why?
|
Infant | 10 | 2024 | 36169 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3093 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3215 | 0.200 |
Why?
|
Cytokines | 5 | 2024 | 7386 | 0.180 |
Why?
|
Coronary Aneurysm | 1 | 2023 | 233 | 0.180 |
Why?
|
Eczema | 1 | 2023 | 246 | 0.180 |
Why?
|
Methotrexate | 2 | 2019 | 1718 | 0.180 |
Why?
|
Advisory Committees | 2 | 2023 | 788 | 0.180 |
Why?
|
Biomedical Research | 1 | 2016 | 3434 | 0.170 |
Why?
|
Delphi Technique | 2 | 2021 | 848 | 0.170 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2023 | 4574 | 0.170 |
Why?
|
Registries | 1 | 2016 | 8247 | 0.170 |
Why?
|
Interferon Type I | 1 | 2023 | 557 | 0.170 |
Why?
|
Interleukin-1 | 1 | 2023 | 1250 | 0.160 |
Why?
|
Immunophenotyping | 2 | 2021 | 1867 | 0.160 |
Why?
|
T-Lymphocyte Subsets | 2 | 2018 | 1803 | 0.160 |
Why?
|
Receptors, IgG | 1 | 2022 | 558 | 0.160 |
Why?
|
Thrombophilia | 1 | 2021 | 306 | 0.160 |
Why?
|
Uveitis, Anterior | 1 | 2019 | 101 | 0.150 |
Why?
|
Synovial Membrane | 1 | 2021 | 532 | 0.150 |
Why?
|
Receptors, Interleukin-1 | 1 | 2019 | 262 | 0.150 |
Why?
|
Diagnosis, Differential | 4 | 2024 | 12976 | 0.150 |
Why?
|
Serpins | 1 | 2019 | 247 | 0.150 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2021 | 4372 | 0.150 |
Why?
|
B-Lymphocytes | 3 | 2023 | 4744 | 0.150 |
Why?
|
Male | 24 | 2024 | 360693 | 0.150 |
Why?
|
Retrospective Studies | 10 | 2024 | 80674 | 0.140 |
Why?
|
Female | 27 | 2024 | 392544 | 0.140 |
Why?
|
Nitriles | 1 | 2022 | 971 | 0.140 |
Why?
|
Leukocytes, Mononuclear | 2 | 2021 | 1838 | 0.130 |
Why?
|
Arthritis | 1 | 2022 | 681 | 0.130 |
Why?
|
Th1 Cells | 1 | 2021 | 1042 | 0.130 |
Why?
|
Tuberculosis, Bovine | 1 | 2015 | 8 | 0.130 |
Why?
|
Candidiasis, Chronic Mucocutaneous | 1 | 2015 | 19 | 0.130 |
Why?
|
Host-Pathogen Interactions | 2 | 2021 | 1448 | 0.130 |
Why?
|
Blood Coagulation | 1 | 2021 | 1156 | 0.120 |
Why?
|
Central Nervous System Diseases | 1 | 2019 | 521 | 0.120 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2023 | 5666 | 0.120 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1791 | 0.120 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2015 | 152 | 0.120 |
Why?
|
Lupus Erythematosus, Systemic | 2 | 2024 | 2157 | 0.110 |
Why?
|
Autoantibodies | 1 | 2023 | 2119 | 0.110 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2019 | 826 | 0.110 |
Why?
|
Temporomandibular Joint Disorders | 1 | 2016 | 222 | 0.110 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2011 | 0.110 |
Why?
|
Lung Diseases, Interstitial | 1 | 2022 | 918 | 0.110 |
Why?
|
C-Reactive Protein | 2 | 2022 | 3821 | 0.110 |
Why?
|
Monocytes | 1 | 2022 | 2570 | 0.100 |
Why?
|
Age of Onset | 2 | 2024 | 3307 | 0.100 |
Why?
|
Candida albicans | 1 | 2015 | 372 | 0.100 |
Why?
|
Chemokine CXCL9 | 2 | 2024 | 135 | 0.100 |
Why?
|
Adenylate Kinase | 1 | 2012 | 102 | 0.100 |
Why?
|
Pyrazoles | 1 | 2022 | 2010 | 0.100 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2018 | 2549 | 0.100 |
Why?
|
Immunologic Factors | 1 | 2021 | 1589 | 0.100 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1878 | 0.100 |
Why?
|
Histones | 1 | 2021 | 2570 | 0.090 |
Why?
|
Consanguinity | 1 | 2012 | 457 | 0.090 |
Why?
|
Hypersensitivity | 1 | 2019 | 1167 | 0.090 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2451 | 0.090 |
Why?
|
Pyrimidines | 1 | 2022 | 3027 | 0.090 |
Why?
|
Infant, Newborn | 4 | 2021 | 26199 | 0.090 |
Why?
|
Risk Factors | 4 | 2024 | 74239 | 0.080 |
Why?
|
Immunosuppressive Agents | 2 | 2019 | 4190 | 0.080 |
Why?
|
Mutation | 6 | 2018 | 30002 | 0.080 |
Why?
|
Immunity | 1 | 2015 | 996 | 0.080 |
Why?
|
Neutrophils | 1 | 2022 | 3763 | 0.080 |
Why?
|
Adult | 11 | 2023 | 221119 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2021 | 2746 | 0.080 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2015 | 830 | 0.080 |
Why?
|
Anticoagulants | 2 | 2021 | 4795 | 0.080 |
Why?
|
Respiratory Function Tests | 1 | 2013 | 1685 | 0.070 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39126 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 3788 | 0.070 |
Why?
|
Incidence | 2 | 2023 | 21365 | 0.070 |
Why?
|
DNA Methylation | 1 | 2021 | 4384 | 0.070 |
Why?
|
Socioeconomic Factors | 1 | 2021 | 7804 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3691 | 0.070 |
Why?
|
Case-Control Studies | 2 | 2021 | 22174 | 0.070 |
Why?
|
Cross-Sectional Studies | 3 | 2016 | 26071 | 0.070 |
Why?
|
Interferon-gamma | 3 | 2022 | 3155 | 0.070 |
Why?
|
Syndrome | 1 | 2013 | 3271 | 0.070 |
Why?
|
Severity of Illness Index | 1 | 2024 | 15841 | 0.070 |
Why?
|
Macrophages | 1 | 2021 | 5753 | 0.070 |
Why?
|
Cell Differentiation | 2 | 2021 | 11509 | 0.070 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6304 | 0.060 |
Why?
|
Pain Measurement | 3 | 2022 | 3549 | 0.060 |
Why?
|
Prognosis | 2 | 2024 | 29687 | 0.060 |
Why?
|
Physicians | 1 | 2023 | 4584 | 0.060 |
Why?
|
DNA-Binding Proteins | 2 | 2022 | 9566 | 0.060 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2731 | 0.060 |
Why?
|
Interleukin-17 | 2 | 2023 | 913 | 0.060 |
Why?
|
Cells, Cultured | 2 | 2016 | 18926 | 0.060 |
Why?
|
Quality Improvement | 1 | 2019 | 3808 | 0.060 |
Why?
|
Phenotype | 3 | 2022 | 16575 | 0.050 |
Why?
|
Wiskott-Aldrich Syndrome Protein | 1 | 2023 | 161 | 0.050 |
Why?
|
Interleukin-15 | 1 | 2023 | 185 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2017 | 5782 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 2 | 2021 | 17897 | 0.050 |
Why?
|
Family | 1 | 2013 | 3192 | 0.050 |
Why?
|
Algorithms | 2 | 2021 | 14025 | 0.050 |
Why?
|
HLA-DR Antigens | 1 | 2023 | 606 | 0.050 |
Why?
|
Pore Forming Cytotoxic Proteins | 1 | 2022 | 130 | 0.050 |
Why?
|
Brain | 2 | 2019 | 27092 | 0.050 |
Why?
|
Radiography | 1 | 2013 | 6974 | 0.050 |
Why?
|
Cathepsin G | 1 | 2021 | 31 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7400 | 0.050 |
Why?
|
Young Adult | 4 | 2021 | 59221 | 0.050 |
Why?
|
Phosphate-Binding Proteins | 1 | 2022 | 92 | 0.050 |
Why?
|
Caspase 1 | 1 | 2022 | 226 | 0.050 |
Why?
|
Autoimmune Diseases | 1 | 2013 | 2244 | 0.050 |
Why?
|
Myeloblastin | 1 | 2021 | 101 | 0.050 |
Why?
|
Leukocyte Elastase | 1 | 2021 | 114 | 0.040 |
Why?
|
Enzyme Assays | 1 | 2021 | 104 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8663 | 0.040 |
Why?
|
Receptor, Notch1 | 1 | 2023 | 497 | 0.040 |
Why?
|
Jurkat Cells | 1 | 2021 | 739 | 0.040 |
Why?
|
United States | 3 | 2023 | 72339 | 0.040 |
Why?
|
Thrombelastography | 1 | 2021 | 187 | 0.040 |
Why?
|
Proteomics | 2 | 2023 | 3840 | 0.040 |
Why?
|
Blood Sedimentation | 1 | 2019 | 235 | 0.040 |
Why?
|
Immune System Diseases | 1 | 2021 | 255 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 425 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2021 | 801 | 0.040 |
Why?
|
Macrophage-Activating Factors | 1 | 2017 | 21 | 0.040 |
Why?
|
Chemokine CXCL13 | 1 | 2017 | 59 | 0.030 |
Why?
|
Inflammasomes | 1 | 2022 | 526 | 0.030 |
Why?
|
Receptors, CXCR5 | 1 | 2017 | 88 | 0.030 |
Why?
|
Mice | 5 | 2022 | 81326 | 0.030 |
Why?
|
Dermatomyositis | 1 | 2019 | 258 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2017 | 190 | 0.030 |
Why?
|
Fever | 1 | 2023 | 1618 | 0.030 |
Why?
|
Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 2015 | 32 | 0.030 |
Why?
|
Antibodies | 1 | 2023 | 2415 | 0.030 |
Why?
|
Epigenomics | 1 | 2021 | 944 | 0.030 |
Why?
|
Radiation, Ionizing | 1 | 2016 | 252 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2021 | 14392 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2020 | 1176 | 0.030 |
Why?
|
Cephalometry | 1 | 2016 | 377 | 0.030 |
Why?
|
Lymphocyte Subsets | 1 | 2016 | 312 | 0.030 |
Why?
|
Mycobacterium bovis | 1 | 2015 | 146 | 0.030 |
Why?
|
Agammaglobulinemia | 1 | 2016 | 172 | 0.030 |
Why?
|
Granulocytes | 1 | 2016 | 550 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2016 | 781 | 0.030 |
Why?
|
Receptors, Chemokine | 1 | 2017 | 654 | 0.030 |
Why?
|
Gene Order | 1 | 2013 | 168 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2024 | 5250 | 0.030 |
Why?
|
Alleles | 2 | 2015 | 6857 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2015 | 346 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2019 | 1436 | 0.030 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2016 | 455 | 0.030 |
Why?
|
Knee Joint | 1 | 2021 | 1678 | 0.030 |
Why?
|
Reference Values | 1 | 2019 | 4921 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2021 | 2881 | 0.030 |
Why?
|
Interleukins | 1 | 2017 | 782 | 0.020 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2020 | 1725 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2021 | 4243 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2018 | 1112 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2015 | 800 | 0.020 |
Why?
|
Animals | 5 | 2022 | 168079 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2021 | 6504 | 0.020 |
Why?
|
Central Nervous System | 1 | 2018 | 1333 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2023 | 3388 | 0.020 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2013 | 646 | 0.020 |
Why?
|
Blood Platelets | 1 | 2021 | 2477 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2019 | 1852 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2022 | 3571 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2020 | 3210 | 0.020 |
Why?
|
Thymus Gland | 1 | 2015 | 1243 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2019 | 4822 | 0.020 |
Why?
|
Aspirin | 1 | 2021 | 3129 | 0.020 |
Why?
|
Cattle | 1 | 2015 | 3818 | 0.020 |
Why?
|
Chromatin | 1 | 2021 | 2946 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2013 | 1125 | 0.020 |
Why?
|
Pilot Projects | 1 | 2022 | 8642 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8837 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6781 | 0.020 |
Why?
|
Pedigree | 1 | 2015 | 4537 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2018 | 5478 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2015 | 4107 | 0.020 |
Why?
|
Middle Aged | 3 | 2019 | 220853 | 0.020 |
Why?
|
Pain | 1 | 2021 | 5072 | 0.020 |
Why?
|
Genetic Variation | 1 | 2021 | 6567 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2017 | 2974 | 0.020 |
Why?
|
Protein Binding | 1 | 2018 | 9297 | 0.020 |
Why?
|
Fibroblasts | 1 | 2016 | 4137 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12728 | 0.020 |
Why?
|
Gene Expression | 1 | 2018 | 7571 | 0.020 |
Why?
|
Cell Movement | 1 | 2017 | 5195 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14675 | 0.010 |
Why?
|
Mycobacterium tuberculosis | 1 | 2015 | 1912 | 0.010 |
Why?
|
Aging | 1 | 2022 | 8702 | 0.010 |
Why?
|
Cell Line | 1 | 2016 | 15545 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 22127 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 9416 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13511 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20588 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 36415 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 64681 | 0.010 |
Why?
|